Male (n=14,921) and female (n=8038)
characteristics were different regarding age (66.2±14.2 vs 67.2±14.4 years),
normal functional status (40.2% vs 33.2%), cardiovascular disease (58.3% vs 48%)
and obesity rate (body mass index BMI>30 kg/m2:
16.1% vs 25.7%) (for all comparisons, p<0.001).
The distribution of the first
VA used for starting HD was different in men vs women: fistulae AVF (46.1%,
n=6308 vs 41.3%, n=3088), graft AVG (0.8%, n=108 vs 1.7%%, n=129) and tunnelled
catheter (20.4%, n=2789 vs 23%, n=1719) (for all comparisons, p<0.001);
without differences for non-tunnelled
catheter (32.8%, n=4488 vs 34%, n=2537) (p=0.083).
Probability of starting HD by AVF: it was
independently associated with male gender (odds ratio 1.32 [95% confidence
interval: 1.23–1.41], p<0.001) after adjusting for age, primary
kidney disease, functional status, BMI, cardiovascular disease
and ESKD presentation (multivariate logistic regression analysis).
By using
a competing risk model, the hazard ratio (HR)
for receiving a kidney graft (KG) within five years from starting HD, depending
on the first VA used to start HD (AVF vs catheter), was: 1.82 (95% CI:
1.69-1.95, p<0.001) for men and 2.32 (95% CI: 2.11-2.55, p<0.001) for
women. In comparison with men that started HD by AVF, the HR of women for receiving a KG within five years
from starting HD by AVF was 1.12 (95% CI: 1.04-1.21, p=0.002). In
comparison with women that started HD by catheter, the HR of men for receiving a KG within five years
from starting HD by catheter was 1.13 (95% CI: 1.03-1.24, p=0.007).
The HR of death within five years from starting HD,
depending on the first VA used to start HD (catheter vs AVF), was: 1.55 (95%
CI: 1.47-1.63, p<0.001) for men and 1.95 (95% CI: 1.81-2.11, p<0.001) for
women. In comparison with men that started HD by
catheter, the HR of death for
women within five years from starting HD by catheter was 1.01 (95% CI:
0.95-1.06, p=0.81). In comparison with women that started HD by AVF,
the HR of death for men within five years
from starting HD by AVF was 1.26 (95% CI: 1.17-1.36, p<0.001)